Molecular cloning and expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid protein and its clinical application.
- Author:
Jian LU
1
;
Bai-ping ZHOU
;
Yu-sen ZHOU
;
Xiao-ling JIANG
;
Li-xia WEN
;
Xiao-hua LE
;
Bing LI
;
Liu-mei XU
;
Li-xiong LI
Author Information
- Publication Type:Journal Article
- MeSH: Antibodies, Viral; blood; Blotting, Western; Cloning, Molecular; Enzyme-Linked Immunosorbent Assay; Gene Expression; Genome, Viral; Humans; Immunoglobulin G; blood; Nucleocapsid Proteins; genetics; immunology; metabolism; RNA, Viral; genetics; Recombinant Proteins; isolation & purification; metabolism; Reverse Transcriptase Polymerase Chain Reaction; SARS Virus; genetics; immunology; isolation & purification; metabolism; Severe Acute Respiratory Syndrome; blood; diagnosis; virology
- From: Chinese Journal of Experimental and Clinical Virology 2005;19(1):64-67
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo clone and express nucleocapsid (N) protein of the severe acute respiratory syndrome (SARS)-associated coronavirus, and to evaluate its antigenicity and application value in the development of serological diagnostic test for SARS.
METHODSSARS-associated coronavirus N protein gene was amplified from its genomic RNA by reverse transcript nested polymerase chain reaction (RT-nested-PCR) and cloned into pBAD/Thio-TOPO prokaryotic expression vector. The recombinant N fusion protein was expressed and purified, and its antigenicity and specificity was analyzed by Western Blot, to establish the recombinant N protein-based ELISA for detection of IgG antibodies to SARS-associated coronavirus, and SARS-associated coronavirus lysates-based ELISA was compared parallelly.
RESULTSThe recombinant expression vector produced high level of the N fusion protein after induction, and that protein was purified successfully by affinity chromatography and displayed higher antigenicity and specificity as compared with whole virus lysates.
CONCLUSIONThe recombinant SARS-associated coronavirus N protein possessed better antigenicity and specificity and could be employed to establish a new, sensitive, and specific ELISA for SARS diagnosis.